Exome Sequencing Study in Cardiomyopathy to Identify New Risk Variants
NCT ID: NCT03754101
Last Updated: 2023-02-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
4000 participants
OBSERVATIONAL
2003-03-03
2025-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetic Analysis of Familial Hypertrophic Cardiomyopathy
NCT00005251
Identification of Genetic Markers Modulating Rhythmic Risk Among Patients With Severe Cardiomyopathy
NCT02852018
Genetic Characterization of Patients With Arrhythmia-Induced Cardiomyopathy
NCT06896266
The Genetics of Dilated Cardiomyopathy: A Quebec-Based Study
NCT00523653
Mapping Novel Disease Genes for Dilated Cardiomyopathy
NCT00046618
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Mild ischemic heart disease
* Significant systemic infection
* Thyroid-induced cardiomyopathy
* Excessive alcohol consumption
* Precious cancer treatment including irradiation
* Refusal to participate in the study
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tongji Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dao Wen Wang
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dao Wen Wang, Doctor
Role: STUDY_CHAIR
Tongji Hospital,Wuhan, Hubei, China, 430030
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tongji Hospital
Wuhan, Hubei, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Li S, Sun Y, Hu S, Hu D, Li C, Xiao L, Chen Y, Li H, Cui G, Wang DW. Genetic risk scores to predict the prognosis of chronic heart failure patients in Chinese Han. J Cell Mol Med. 2020 Jan;24(1):285-293. doi: 10.1111/jcmm.14722. Epub 2019 Oct 31.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TJ-DM-GENE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.